Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Lung cancer remains a leading cause of cancer mortality globally.
• Current therapeutic strategies for lung cancer face limitations due to drug resistance and limited options.
• MicroRNAs (miRNAs) have emerged as critical regulators of cell cycle progression in lung cancer.

Purpose of the Study:

• To review recent advancements in lung cancer therapy utilizing cell cycle-linked miRNAs.
• To elucidate the roles of specific cell cycle regulator-affiliated miRNAs in lung cancer progression.
• To explore the potential of miRNAs in early diagnosis and novel treatment strategies for lung cancer.

Main Methods:

• Literature review of recent studies on miRNA and cell cycle regulation in lung cancer.
• Analysis of the roles of specific miRNAs targeting core cell cycle regulators.
• Synthesis of information regarding miRNA-based diagnostic and therapeutic approaches.

Main Results:

• Cell cycle regulation by miRNAs significantly influences lung cancer progression.
• Specific miRNAs are identified as key players in regulating cell cycle pathways in lung cancer.
• miRNAs demonstrate potential as biomarkers for early diagnosis and as therapeutic agents.

Conclusions:

• Targeting cell cycle-linked miRNAs presents a promising strategy for overcoming therapeutic challenges in lung cancer.
• Further research into miRNA-based interventions could lead to breakthroughs in lung cancer treatment and prevention.
• miRNAs hold potential for improving early detection and developing novel therapeutic modalities for lung cancer.